
An analysis of CGON's $25.00 strike put option, with a $0.20 bid, presents an alternative acquisition strategy for investors, allowing for a net cost basis of $24.80 compared to the current $26.88 share price. This out-of-the-money contract, approximately 7% below the current price, carries a 64% probability of expiring worthless, offering a 4.56% annualized return on the cash commitment. The option's 78% implied volatility contrasts with CGON's 65% historical volatility, highlighting a potential opportunity for premium collection.
An analysis of a specific CG Oncology Inc. (CGON) options contract reveals a strategy for investors to either acquire the stock at a discount or generate income. By selling the $25.00 strike put option for a $0.20 premium, an investor establishes an effective purchase price of $24.80 per share if assigned, a 7% discount to the current price of $26.88. Alternatively, if the stock remains above the strike price at expiration, the contract has a 64% calculated probability of expiring worthless, allowing the seller to retain the premium. This outcome would generate a 0.80% return on the cash commitment, which annualizes to 4.56%. A key data point is the divergence between the option's implied volatility of 78% and the stock's actual trailing twelve-month volatility of 65%, indicating that the option's premium is relatively rich compared to the stock's recent price behavior, a condition that typically favors option sellers.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mildly positive
Sentiment Score
0.35
Ticker Sentiment